Last checked at 6 Oct 2017 07:00
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Issue of Equity
The neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets software products to improve brain health, announces that it has applied to the London Stock Exchange for 225,135 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercise of options over Ordinary Shares by a former employee of the Company under the Company's Share Option Scheme.
It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 11 October 2017. On Admission the Company's issued share capital will comprise 20,697,870 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 20,697,870 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Cambridge Cognition Holdings plc | www.cambridgecognition.com |
Steven Powell, Chief Executive Officer | Tel: 01223 810 700 |
Nick Walters, Chief Financial Officer
| |
finnCap Ltd (Nomad & Joint Broker) | Tel: 020 7220 0500 |
Geoff Nash / Simon Hicks | (Corporate Finance) |
Alice Lane | (Corporate Broking)
|
Dowgate Capital Stockbrokers Limited (Joint Broker) | Tel: 020 3903 7715 |
David Poutney/ James Serjeant | (Corporate Broking) |